ArticleDiscover oncology2025

ADCYAP1 as a pan-solid cancer biomarker: predictor of immunotherapy efficacy in bladder cancer and prognostic potential across solid tumors.

Xiaoyu Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.